1048 / 1708
AREN0532/AREN0533
1134
35 (3.1%)
LOH 1p and 16q
Stage I/II
DD4A without RT
52 (4.6%)
LOH 1p and 16q
Stage III/IV
Regimen M with RT
1047
No LOH 1p and 16q
Stage I/II/III/IV
EE4A for Stage I/II
DD4A for Stage
III/IV with RT*
Dix DB et al. J Clin Oncol 33, 2015 (suppl; abstr
10009)